Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

The Lancet

Volumn 373, Issue 9665, 2009, Pages 739-745

  Schnabel, Renate B ^a,h   Sullivan, Lisa M ^b   Levy, Daniel ^a,d,e   Pencina, Michael J ^a,b   Massaro, Joseph M ^b   D'Agostino Sr , Ralph B ^c   Newton Cheh, Christopher ^a,f,g   Yamamoto, Jennifer F ^a,b   Magnani, Jared W ^d   Tadros, Thomas M ^a,d   Kannel, William B ^a,b,d   Wang, Thomas J ^a,f   Ellinor, Patrick T ^f   Wolf, Philip A ^a,d   Vasan, Ramachandran S ^a,d   Benjamin, Emelia J ^a,b,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c Boston University   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^h JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CLASSIFICATION; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY ASSESSMENT; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MURMUR; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; PR INTERVAL; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SECONDARY ANALYSIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 60649118584     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60443-8     Document Type: Article

References (35)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
2. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
3. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., and Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
4. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 120 (2007) 357-363
5. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003) 2920-2925
6. Shinbane J.S., Wood M.A., Jensen D.N., Ellenbogen K.A., Fitzpatrick A.P., and Scheinman M.M. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29 (1997) 709-715
7. Ringborg A., Nieuwlaat R., Lindgren P., et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 10 (2008) 403-411
8. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 (1994) 840-844
9. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
10. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471-2477
11. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98 (1995) 476-484
12. Frost L., Hune L.J., and Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 118 (2005) 489-495
13. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96 (1997) 2455-2461
14. Benjamin E.J., Chen P.S., Bild D.E., et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation 119 (2009) 606-618
15. Dawber T., Meadors G., and Moore Jr. F. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 41 (1951) 279-281
16. Quan S.F., Howard B.V., Iber C., et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 20 (1997) 1077-1085
17. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
18. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., and Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 (1993) 107-115
19. Vaziri S.M., Larson M.G., Benjamin E.J., and Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89 (1994) 724-730
20. D'Agostino R.B., Lee M.L., Belanger A.J., Cupples L.A., Anderson K., and Kannel W.B. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 9 (1990) 1501-1515
21. Sullivan L.M., Massaro J.M., and D'Agostino Sr. R.B. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 23 (2004) 1631-1660
22. D'Agostino R.B., and Nam B.H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Balakrishnan N., and Rao C.R. (Eds). Handbook of statistics (2004), Elsevier, Amsterdam 1-25
23. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
24. Fauchier L., Pierre B., de Labriolle A., Grimard C., Zannad N., and Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 51 (2008) 828-835
25. Healey J.S., Baranchuk A., Crystal E., et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 45 (2005) 1832-1839
26. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49 (2007) 565-571
27. Dilaveris P.E., Gialafos E.J., Sideris S.K., et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135 (1998) 733-738
28. Darbar D., Jahangir A., Hammill S.C., and Gersh B.J. P wave signal-averaged electrocardiography to identify risk for atrial fibrillation. Pacing Clin Electrophysiol 25 (2002) 1447-1453
29. Yamada T., Fukunami M., Shimonagata T., et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J 20 (1999) 211-220
30. Soliman E.Z., and Goff Jr. D.C. The paradox of racial distribution of atrial fibrillation. J Natl Med Assoc 100 (2008) 447-448
31. Eichler K., Puhan M.A., Steurer J., and Bachmann L.M. Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J 153 (2007) 722-731 731.e1-8.
32. Cappola A.R., Fried L.P., Arnold A.M., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295 (2006) 1033-1041
33. Mozaffarian D., Furberg C.D., Psaty B.M., and Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 118 (2008) 800-807
34. Mont L., Tamborero D., Elosua R., et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 10 (2008) 15-20
35. Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (2004) 1042-1046